Christopher Wolven - Item 9 Chief Officer

INLB Stock  USD 0.0001  0.00  0.00%   

Insider

Christopher Wolven is Chief Officer of Item 9 Labs
Age 40
Phone833 867 6337
Webhttps://www.item9labscorp.com

Item 9 Management Efficiency

The company has return on total asset (ROA) of (0.0721) % which means that it has lost $0.0721 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4212) %, meaning that it created substantial loss on money invested by shareholders. Item 9's management efficiency ratios could be used to measure how well Item 9 manages its routine affairs as well as how well it operates its assets and liabilities.
Item 9 Labs currently holds 7.22 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Item 9 Labs has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Item 9 until it has trouble settling it off, either with new capital or with free cash flow. So, Item 9's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Item 9 Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Item to invest in growth at high rates of return. When we think about Item 9's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

INSIDER Age

Sonny NewmanC21 Investments
N/A
Obie StricklerGrown Rogue International
40
Buddy WilsonGrown Rogue International
N/A
Ryan KeeGrown Rogue International
40
Steven LightmanGrown Rogue International
66
Adam AugustGrown Rogue International
45
Eric ShoemakerC21 Investments
N/A
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 103 people. Item 9 Labs [INLB] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Item 9 Labs Leadership Team

Elected by the shareholders, the Item 9's board of directors comprises two types of representatives: Item 9 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Item. The board's role is to monitor Item 9's management team and ensure that shareholders' interests are well served. Item 9's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Item 9's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mike II, G Counsel
Christopher Wolven, Chief Officer
Jayne Levy, VP Communications
Kyle Jennings, Vice President
Robert Mikkelsen, Treasurer Sec
Michael Weinberger, Chief Director
Cory Carter, VP Cultivation
Mark Busch, Sr Devel
Andrew Bowden, Pres CEO

Item Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Item 9 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Item Pink Sheet

Item 9 financial ratios help investors to determine whether Item Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Item with respect to the benefits of owning Item 9 security.